Kelly J - Search Results

1

Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

Langabeer SE, Haslam K, O'Brien D, Kelly J, Andrews C, Ryan C, Flavin R, Hayden PJ, Bacon CL. Langabeer SE, et al. Among authors: kelly j. Case Rep Hematol. 2016;2016:6545861. doi: 10.1155/2016/6545861. Epub 2016 Jan 21. Case Rep Hematol. 2016. PMID: 26904322 Free PMC article.

2

Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia.

Haslam K, Langabeer SE, Kelly J, Coen N, O'Connell NM, Conneally E. Haslam K, et al. Among authors: kelly j. Case Rep Hematol. 2012;2012:620967. doi: 10.1155/2012/620967. Epub 2012 Oct 2. Case Rep Hematol. 2012. PMID: 23082258 Free PMC article.

3

Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia.

Langabeer SE, Preston L, Kelly J, Goodyer M, Elhassadi E, Hayat A. Langabeer SE, et al. Among authors: kelly j. Case Rep Hematol. 2017;2017:7657393. doi: 10.1155/2017/7657393. Epub 2017 Apr 26. Case Rep Hematol. 2017. PMID: 28529810 Free PMC article.

4

Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.

Langabeer SE, Haslam K, Kelly J, Quinn J, Morrell R, Conneally E. Langabeer SE, et al. Among authors: kelly j. Clin Transl Oncol. 2018 Mar;20(3):420-423. doi: 10.1007/s12094-017-1722-2. Epub 2017 Jul 31. Clin Transl Oncol. 2018. PMID: 28762112

5

Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia.

McCarron SL, Maher K, Kelly J, Ryan MF, Langabeer SE. McCarron SL, et al. Among authors: kelly j. Case Rep Hematol. 2013;2013:490740. doi: 10.1155/2013/490740. Epub 2013 Sep 16. Case Rep Hematol. 2013. PMID: 24109527 Free PMC article.

6

Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.

Crampe M, Haslam K, Kelly J, Conneally E, Langabeer SE. Crampe M, et al. Among authors: kelly j. Hematol Oncol Stem Cell Ther. 2017 Jun;10(2):85-88. doi: 10.1016/j.hemonc.2016.02.002. Epub 2016 Mar 17. Hematol Oncol Stem Cell Ther. 2017. PMID: 27013275 Free article.

7

Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.

Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E. Langabeer SE, et al. Among authors: kelly j. Acta Haematol. 2011;126(4):214-5. doi: 10.1159/000330956. Epub 2011 Sep 16. Acta Haematol. 2011. PMID: 21934295 No abstract available.

8

Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.

Langabeer SE, McCarron SL, Kelly J, Krawczyk J, McPherson S, Perera K, Murphy PT. Langabeer SE, et al. Among authors: kelly j. Case Rep Hematol. 2012;2012:458716. doi: 10.1155/2012/458716. Epub 2012 Jul 2. Case Rep Hematol. 2012. PMID: 22937329 Free PMC article.

9

Incidence and significance of FLT3-ITD and NPM1 mutations in patients with normal karyotype acute myeloid leukaemia.

Haslam K, Chadwick N, Kelly J, Browne P, Vandenberghe E, Flynn C, Conneally E, Langabeer SE. Haslam K, et al. Among authors: kelly j. Ir J Med Sci. 2010 Dec;179(4):507-10. doi: 10.1007/s11845-010-0567-2. Epub 2010 Aug 31. Ir J Med Sci. 2010. PMID: 20803351

10

Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.

McCarron SL, Langabeer SE, Bolger K, Haslam K, Crampe M, Kelly J, Morrell R. McCarron SL, et al. Among authors: kelly j. Med Oncol. 2015 Feb;32(2):452. doi: 10.1007/s12032-014-0452-3. Epub 2015 Jan 13. Med Oncol. 2015. PMID: 25579165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,710 results

Search Page

Filters